FDA to Adopt 'Super Intelligence' Terminology Following Executive Order 14434
On September 29, 2026, the President issued Executive Order 14434, titled 'Inaugurating the Era of Super Intelligence.' This Executive Order mandates that executive departments and agencies, including the U.S. Food and Drug Administration (FDA), use the terms 'Super Intelligence' and 'SI' instead of 'Artificial Intelligence' and 'AI' in official correspondence, public communications, websites, reports, policy documents, and other non-statutory documents. This change is effective as of November 16, 2026. The Executive Order defines 'Super Intelligence' and 'SI' as technologies and systems encompassed by the existing definition of 'artificial intelligence' in 15 U.S.C. 9401(3). The FDA will begin incorporating these new terms into newly issued public-facing documents and communications, and will update existing public-facing documents during their next substantive revision and web content on its regular maintenance cycle. However, where a statute or regulation specifically uses 'artificial intelligence' or '...